DE69816624D1 - Verabreichungsform für sertralin mit verzögerter wirkstofffreigabe - Google Patents

Verabreichungsform für sertralin mit verzögerter wirkstofffreigabe

Info

Publication number
DE69816624D1
DE69816624D1 DE69816624T DE69816624T DE69816624D1 DE 69816624 D1 DE69816624 D1 DE 69816624D1 DE 69816624 T DE69816624 T DE 69816624T DE 69816624 T DE69816624 T DE 69816624T DE 69816624 D1 DE69816624 D1 DE 69816624D1
Authority
DE
Germany
Prior art keywords
sertralin
active substance
substance release
delayed active
administrative form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69816624T
Other languages
English (en)
Other versions
DE69816624T2 (de
Inventor
John Curatolo
Lewis Friedman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971681&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69816624(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Application granted granted Critical
Publication of DE69816624D1 publication Critical patent/DE69816624D1/de
Publication of DE69816624T2 publication Critical patent/DE69816624T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69816624T 1997-07-01 1998-06-16 Verabreichungsform für sertralin mit verzögerter wirkstofffreigabe Expired - Fee Related DE69816624T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5149997P 1997-07-01 1997-07-01
US51499P 1997-07-01
PCT/IB1998/000937 WO1999001122A1 (en) 1997-07-01 1998-06-16 Delayed-release dosage forms of sertraline

Publications (2)

Publication Number Publication Date
DE69816624D1 true DE69816624D1 (de) 2003-08-28
DE69816624T2 DE69816624T2 (de) 2004-02-19

Family

ID=21971681

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69816624T Expired - Fee Related DE69816624T2 (de) 1997-07-01 1998-06-16 Verabreichungsform für sertralin mit verzögerter wirkstofffreigabe

Country Status (41)

Country Link
EP (1) EP1007024B1 (de)
JP (1) JP3786715B2 (de)
KR (1) KR100369698B1 (de)
CN (4) CN1475209A (de)
AP (1) AP1199A (de)
AR (1) AR038394A2 (de)
AT (1) ATE245415T1 (de)
AU (1) AU727152B2 (de)
BG (1) BG64742B1 (de)
BR (1) BR9809895A (de)
CA (1) CA2290969C (de)
DE (1) DE69816624T2 (de)
DK (1) DK1007024T3 (de)
DZ (1) DZ2547A1 (de)
EA (1) EA001906B1 (de)
ES (1) ES2202858T3 (de)
GT (1) GT199800091A (de)
HK (1) HK1027982A1 (de)
HN (1) HN1998000099A (de)
HR (1) HRP980376B1 (de)
HU (1) HUP0301787A3 (de)
ID (1) ID23187A (de)
IL (2) IL152304A0 (de)
IS (1) IS5267A (de)
MA (1) MA24585A1 (de)
NO (1) NO996519L (de)
NZ (1) NZ501249A (de)
OA (1) OA11247A (de)
PA (1) PA8454201A1 (de)
PE (1) PE84399A1 (de)
PL (1) PL337799A1 (de)
PT (1) PT1007024E (de)
SI (1) SI1007024T1 (de)
SK (1) SK173299A3 (de)
TN (1) TNSN98122A1 (de)
TR (1) TR199903295T2 (de)
TW (1) TW575437B (de)
UA (1) UA63953C2 (de)
UY (1) UY25068A1 (de)
WO (1) WO1999001122A1 (de)
ZA (1) ZA985710B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL142896A0 (en) 1998-11-02 2002-04-21 Elan Corp Plc Multiparticulate modified release composition
IE990406A1 (en) 1999-05-20 2000-12-27 Elan Corp Plc Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
DZ3256A1 (fr) * 1999-05-20 2000-11-30 Elan Corp Plc Preparations d'inhibiteurs specifiques du recaptage de la serotonine a liberation multiparticulaire regulee
ES2393582T3 (es) 1999-09-03 2012-12-26 Apbi Holdings, Llc Procedimiento de utilización de inhibidores de la recaptación de serotonina selectivos de inicio rápido de acción para el tratamiento de las disfunciones sexuales
ES2168043B1 (es) * 1999-09-13 2003-04-01 Esteve Labor Dr Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
BRPI0108145B8 (pt) * 2000-02-10 2021-05-25 Bpsi Holdings Inc composições de revestimento entérico acrílicas
MXPA03001771A (es) 2000-08-30 2003-06-04 Pfizer Prod Inc Formulaciones de liberacion sostenida para secretagogos de hormona del crecimiento.
US6482440B2 (en) * 2000-09-21 2002-11-19 Phase 2 Discovery, Inc. Long acting antidepressant microparticles
MXPA03008997A (es) * 2001-04-10 2004-02-12 Sun Pharmaceutical Ind Ltd Composicion de liberacion por impulso temporizado.
WO2003013480A1 (en) * 2001-08-06 2003-02-20 Dr. Reddy's Laboratories Ltd. Improved enteric formulation of fluoxetin
GB0607534D0 (en) * 2006-04-13 2006-05-24 Univ London Pharmacy Colonic drug delivery formulation
EP2586429A1 (de) * 2011-10-26 2013-05-01 Freund Pharmatec Ltd. Arzneimittelabgabevorrichtung mit mehreren Einheiten für pulsierende oder verzögerte Freisetzung
CN108014087A (zh) * 2017-12-27 2018-05-11 江苏联环药业股份有限公司 一种盐酸舍曲林胶囊的制备方法
CN109432038A (zh) * 2018-12-28 2019-03-08 乐普制药科技有限公司 一种含有盐酸舍曲林的肠溶片剂及其制备方法
CN114129540B (zh) * 2021-11-19 2022-07-05 浙江维康药业股份有限公司 一种肝苏胶囊及其制作方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
EP0357364B1 (de) * 1988-08-30 1993-07-28 E.I. Du Pont De Nemours And Company Verfahren zum Flash-Spinnen von trocknen polymeren Tauen aus plexifilamentaren Film-Fibrillen
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane
US4983401A (en) * 1989-05-22 1991-01-08 Kinaform Technology, Inc. Sustained release pharmaceutical preparations having pH controlled membrane coatings

Also Published As

Publication number Publication date
KR100369698B1 (ko) 2003-01-30
TR199903295T2 (xx) 2000-08-21
IL133081A0 (en) 2001-03-19
JP3786715B2 (ja) 2006-06-14
AR038394A2 (es) 2005-01-12
HRP980376A2 (en) 1999-04-30
EP1007024B1 (de) 2003-07-23
EP1007024A1 (de) 2000-06-14
AU7545198A (en) 1999-01-25
AP1199A (en) 2003-08-28
ID23187A (id) 2000-03-23
HRP980376B1 (en) 2002-12-31
CN1261273A (zh) 2000-07-26
EA199900965A1 (ru) 2000-08-28
EA001906B1 (ru) 2001-10-22
BG64742B1 (bg) 2006-02-28
ES2202858T3 (es) 2004-04-01
BG103916A (en) 2000-07-31
CA2290969C (en) 2004-02-17
CN1151783C (zh) 2004-06-02
UA63953C2 (uk) 2004-02-16
OA11247A (en) 2002-11-19
DZ2547A1 (fr) 2003-02-08
NO996519D0 (no) 1999-12-28
IL133081A (en) 2005-09-25
IS5267A (is) 1999-11-23
CN1475208A (zh) 2004-02-18
SI1007024T1 (en) 2003-12-31
AU727152B2 (en) 2000-12-07
CN1494899A (zh) 2004-05-12
TW575437B (en) 2004-02-11
WO1999001122A1 (en) 1999-01-14
NZ501249A (en) 2001-06-29
GT199800091A (es) 1999-12-21
IL152304A0 (en) 2003-05-29
CN1475209A (zh) 2004-02-18
ZA985710B (en) 2000-01-10
ATE245415T1 (de) 2003-08-15
DE69816624T2 (de) 2004-02-19
AP9801278A0 (en) 1998-06-30
SK173299A3 (en) 2000-11-07
NO996519L (no) 2000-02-29
CA2290969A1 (en) 1999-01-14
HUP0301787A2 (hu) 2003-11-28
JP2000513751A (ja) 2000-10-17
MA24585A1 (fr) 1998-12-31
PL337799A1 (en) 2000-09-11
BR9809895A (pt) 2000-08-01
HUP0301787A3 (en) 2005-04-28
HN1998000099A (es) 1998-10-22
PE84399A1 (es) 1999-09-11
PT1007024E (pt) 2003-11-28
UY25068A1 (es) 2000-12-29
KR20010013522A (ko) 2001-02-26
TNSN98122A1 (fr) 2005-03-15
DK1007024T3 (da) 2003-11-17
HK1027982A1 (en) 2001-02-02
PA8454201A1 (es) 2000-09-29

Similar Documents

Publication Publication Date Title
DE69918074D1 (de) Makrolid-formulierung mit verzögerter wirkstoffabgabe
DE69831948D1 (de) Selbständiges zellwachstumssystem
DE69919455D1 (de) Förderer mit mehreren Trennmitteln
DE59807164D1 (de) Sägerät
DE69917746D1 (de) Dreiwegkatalysator
DE69835502D1 (de) Elektrochemisches Bauelement
DE69816624D1 (de) Verabreichungsform für sertralin mit verzögerter wirkstofffreigabe
DE979167T1 (de) Filmstruktur
DE69816760D1 (de) Trennfolie
IT243439Y1 (it) Pacco rotorico perfezionato
ID24203A (id) Pestisidal 1-aril-3-iminopirazol
FI980473A (fi) Mittausjärjestelmä
DE69904255D1 (de) Dosiervorrichtung
DE69922630D1 (de) Trennfolie
ID19856A (id) Piranti stempel
DE59910255D1 (de) Wischerträger
ATE189440T1 (de) Eiertragplatte
DE69836751D1 (de) Dienste mit rufunabhängigen modulen
DE69801679T2 (de) Gesichertes speicherverwaltungsverfahren
DE69904388T2 (de) Drucktuchträgermaterial beziehungsweise Drucktuch
NO995727D0 (no) Baereanordning
DE69906234D1 (de) Gummiervorrichtung
DE59811996D1 (de) Implantat mit Halterung
DE59903316D1 (de) Fallschirm mit aktiver entfaltung
DE69821358D1 (de) Einzelschicht-folie

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee